Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.
Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. However, CCM remains one of the leading causes of mortality among HIV infected patients especially in sub-Saharan Afr...
Main Authors: | Jonathan Kitonsa, Rebecca Nsubuga, Yunia Mayanja, Julius Kiwanuka, Yofesi Nikweri, Martin Onyango, Zacchaeus Anywaine, Abu-Baker Ggayi, Freddie Mukasa Kibengo, Pontiano Kaleebu, Jeremy Day |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-11-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008823 |
Similar Items
-
Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.
by: Jonathan Kitonsa, et al.
Published: (2019-01-01) -
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.
by: Jonathan Kitonsa, et al.
Published: (2021-03-01) -
Cryptococcal meningitis
by: Yun-can WANG, et al.
Published: (2013-01-01) -
Diagnosis and treatment of cryptococcal meningitis and/or cryptococcal meningoencephalitis
by: Yan-yu CHANG, et al.
Published: (2014-08-01) -
Cryptococcal Meningitis in Vietnam
by: Day, Jeremy Noel
Published: (2010)